# TOFACITINIB

NDC: 71085-099
Generic name: Tofacitinib
Labeler / Manufacturer: IPG Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20260615

FDA application: ANDA219370

## Active ingredients

- TOFACITINIB CITRATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71085-099"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71085-099
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd1b61bf-de03-4198-89f6-f3952b79d2c2